Weekly Research Analysts’ Ratings Updates for HCA Healthcare (HCA)

HCA Healthcare (NYSE: HCA) recently received a number of ratings updates from brokerages and research firms:

• 8/3/2026 – HCA Healthcare had its price target raised by Wells Fargo & Company from $369.00 to $381.00. They now have an “equal weight” rating on the stock.
• 7/28/2026 – HCA Healthcare had its price target lowered by The Goldman Sachs Group, Inc. from $558.00 to $485.00. They now have a “buy” rating on the stock.
• 7/28/2026 – HCA Healthcare had its price target lowered by Mizuho from $525.00 to $475.00. They now have an “outperform” rating on the stock.
• 7/27/2026 – HCA Healthcare had its price target lowered by UBS Group AG from $635.00 to $579.00. They now have a “buy” rating on the stock.
• 7/27/2026 – HCA Healthcare was given a new $476.00 price target by Deutsche Bank Aktiengesellschaft.
• 7/27/2026 – HCA Healthcare had its price target lowered by Morgan Stanley from $425.00 to $380.00. They now have an “underweight” rating on the stock.
• 7/27/2026 – HCA Healthcare had its price target lowered by Truist Financial Corporation from $535.00 to $495.00. They now have a “buy” rating on the stock.
• 7/27/2026 – HCA Healthcare had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $435.00 price target on the stock.
• 7/27/2026 – HCA Healthcare had its price target lowered by Oppenheimer Holdings, Inc. from $520.00 to $485.00. They now have an “outperform” rating on the stock.
• 7/27/2026 – HCA Healthcare had its price target lowered by KeyCorp from $475.00 to $435.00. They now have an “overweight” rating on the stock.
• 7/27/2026 – HCA Healthcare had its price target lowered by Barclays PLC from $402.00 to $387.00. They now have an “equal weight” rating on the stock.
• 7/27/2026 – HCA Healthcare had its price target lowered by Robert W. Baird from $396.00 to $393.00. They now have a “neutral” rating on the stock.
• 7/20/2026 – HCA Healthcare was given a new $369.00 price target by Wells Fargo & Company.
• 7/16/2026 – HCA Healthcare had its price target lowered by Barclays PLC from $427.00 to $402.00. They now have an “equal weight” rating on the stock.
• 7/15/2026 – HCA Healthcare had its “market perform” rating reaffirmed by Sanford C. Bernstein.
• 7/15/2026 – HCA Healthcare had its price target lowered by Royal Bank Of Canada from $534.00 to $435.00. They now have an “outperform” rating on the stock.
• 7/14/2026 – HCA Healthcare was given a new $450.00 price target by Jefferies Financial Group Inc..
• 7/14/2026 – HCA Healthcare had its price target lowered by KeyCorp from $510.00 to $475.00. They now have an “overweight” rating on the stock.
• 7/13/2026 – HCA Healthcare had its price target lowered by Wells Fargo & Company from $436.00 to $428.00. They now have an “equal weight” rating on the stock.
• 7/8/2026 – HCA Healthcare was downgraded by Barclays PLC from “overweight” to “equal weight”. They now have a $427.00 price target on the stock, down from $496.00.
• 7/8/2026 – HCA Healthcare had its “equal weight” rating reaffirmed by Barclays PLC. They now have a $427.00 price target on the stock, down from $496.00.
• 7/7/2026 – HCA Healthcare was given a new $528.00 price target by Raymond James Financial, Inc..
• 7/7/2026 – HCA Healthcare had its price target lowered by Cantor Fitzgerald from $588.00 to $525.00. They now have an “overweight” rating on the stock.
• 7/1/2026 – HCA Healthcare had its “overweight” rating reaffirmed by Cantor Fitzgerald.
• 6/22/2026 – HCA Healthcare had its price target lowered by TD Cowen from $500.00 to $431.00. They now have a “buy” rating on the stock.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.45%.

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.